DC Field | Value | Language |
---|---|---|
dc.contributor.author | J Y Chung | - |
dc.contributor.author | F A Pasha | - |
dc.contributor.author | S J Cho | - |
dc.contributor.author | Mi Sun Won | - |
dc.contributor.author | Jung Joon Lee | - |
dc.contributor.author | Kyeong Lee | - |
dc.date.accessioned | 2017-04-19T09:13:31Z | - |
dc.date.available | 2017-04-19T09:13:31Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | 10.1007/s12272-009-1301-3 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/8890 | - |
dc.description.abstract | (Aryloxyamino)benzoic acids and nicotinic/isonicotinic acids represent an important new class of small molecules that inhibit the activation of Hypoxia-Inducible Factor (HIF)-1. In order to understand the factors affecting inhibitory potency of HIF-1 inhibitors, 3 dimensional-quantitative structure activity relationship (3D-QSAR) studies were performed. Since no receptor structure are available, the pharmacophore-based alignment was used for comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). The CoMFA and CoMSIA models gave reasonable statistics (CoMFA: q2 = 0.564, r2=0.945; CoMSIA: q2 = 0.575, r2=0.929). Both CoMFA and CoMSIA results indicate that the steric interaction is a major factor, while CoMSIA suggests importance of hydrogen bonding. These findings about steric and H-bonding effects can be useful to design new inhibitors. | - |
dc.publisher | Pharmaceutical Soc Korea | - |
dc.title | Pharmacophore-based 3D-QSAR of HIF-1 Inhibitors | - |
dc.title.alternative | Pharmacophore-based 3D-QSAR of HIF-1 Inhibitors | - |
dc.type | Article | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.number | 3 | - |
dc.citation.endPage | 323 | - |
dc.citation.startPage | 317 | - |
dc.citation.volume | 32 | - |
dc.contributor.affiliatedAuthor | Mi Sun Won | - |
dc.contributor.affiliatedAuthor | Jung Joon Lee | - |
dc.contributor.affiliatedAuthor | Kyeong Lee | - |
dc.contributor.alternativeName | 정재윤 | - |
dc.contributor.alternativeName | Pasha | - |
dc.contributor.alternativeName | 조승주 | - |
dc.contributor.alternativeName | 원미선 | - |
dc.contributor.alternativeName | 이정준 | - |
dc.contributor.alternativeName | 이경 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, vol. 32, no. 3, pp. 317-323 | - |
dc.identifier.doi | 10.1007/s12272-009-1301-3 | - |
dc.subject.keyword | 3D-QSAR | - |
dc.subject.keyword | CoMFA | - |
dc.subject.keyword | CoMSIA | - |
dc.subject.keyword | drug design | - |
dc.subject.keyword | HIF-1 inhibitor | - |
dc.subject.keyword | pharmacophore | - |
dc.subject.local | 3D-QSAR | - |
dc.subject.local | CoMFA | - |
dc.subject.local | CoMSIA | - |
dc.subject.local | drug design | - |
dc.subject.local | Drug design | - |
dc.subject.local | HIF-1 inhibitor | - |
dc.subject.local | pharmacophore | - |
dc.subject.local | Pharmacophore | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.